SCHEMBL24344074

SCHEMBL24344074

CC(CCC(C)c1ccnc(C(C)(C)C)n1)c1cncc(C(C)(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21937639 0.78 — —
SCHEMBL21341478 0.78 — —
SCHEMBL21341339 0.76 HMGCR (0.31) —
SCHEMBL1912979 0.70 CHRNA7 (0.33) —
SCHEMBL1702135 0.69 HMGCR (0.36) —
SCHEMBL18532053 0.68 ADORA2A (0.31) —
SCHEMBL25466578 0.66 — —
SCHEMBL23767706 0.65 — —
SCHEMBL279200 0.65 SYK (0.39) —
SCHEMBL25998007 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230144211-A1 ANTIFOLATE LINKER-DRUGS AND ANTIBODY-DRUG CONJUGATES BYONDIS B.V. (NL) 2023-05-11 — — US disclosed
US-20220119392-A1 ANTIFOLATE LINKER-DRUGS AND ANTIBODY-DRUG CONJUGATES BYONDIS B.V. (NL) 2022-04-21 — — US disclosed
Send feedback